FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Company News
March 20, 2018 / 12:38 AM / 5 months ago

BRIEF-Helix Biopharma Reports Q2 Loss Per Share of C$0.03

Reuters Staff

1 Min Read

March 19 (Reuters) - Helix Biopharma Corp:

* . ANNOUNCES FISCAL SECOND QUARTER 2018 RESULTS

* Q2 LOSS PER SHARE C$0.03 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    © 2018 Reuters. All Rights Reserved.